United States Non-Invasive Prenatal Testing Analysis Report 2025: Market to Triple to Reach $3.24 Billion by 2033 - Focus on Down Syndrome, Edwards Syndrome, Patau Syndrome, Turner Syndrom...
Natera, Inc. (NTRA)
Last natera, inc. earnings: 2/26 04:10 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.natera.com
Company Research
Source: Yahoo! Finance
The expansion is driven by technological advancements, improved insurance coverage, rising awareness, and a growing prevalence of genetic disorders. NIPT is gaining prominence due to its safety, non-invasiveness, and accuracy in detecting chromosomal abnormalities, such as Down syndrome, trisomy 18, and trisomy 13. As professional organizations like ACOG support its use for all pregnancies, NIPT's adoption is expected to accelerate, offering safer prenatal screening options. Dublin, May 29, 2025 (GLOBE NEWSWIRE) -- The "United States Non-Invasive Prenatal Testing Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering. The safety of non-invasive techniques, more awareness, better insurance coverage, technological improvements, and an increase in genetic diseases are the main factors propelling the non-invasive prenatal testing market in the United States. Technological developments and growing medic
Show less
Read more
Impact Snapshot
Event Time:
NTRA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NTRA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NTRA alerts
High impacting Natera, Inc. news events
Weekly update
A roundup of the hottest topics
NTRA
News
- Natera (NASDAQ:NTRA) had its price target raised by analysts at Canaccord Genuity Group Inc. from $250.00 to $285.00. They now have a "buy" rating on the stock.MarketBeat
- Natera to Participate in the 44th Annual J.P. Morgan Healthcare ConferenceBusiness Wire
- Natera Announces Publication of Signatera™ Analysis from Randomized, Phase III CALGB (Alliance)/SWOG 80702 Study in Colorectal CancerBusiness Wire
- I-SPY 2 Publication in Nature Communications Shows Signatera™ Can Predict Treatment Response and Recurrence Risk in Early-Stage Breast CancerBusiness Wire
- Natera (NASDAQ:NTRA) had its price target raised by analysts at JPMorgan Chase & Co. from $250.00 to $260.00. They now have an "overweight" rating on the stock.MarketBeat
NTRA
Earnings
- 11/6/25 - Miss
NTRA
Sec Filings
- 12/22/25 - Form 4
- 12/19/25 - Form 144
- 12/17/25 - Form 4
- NTRA's page on the SEC website